COMMUNIQUÉS West-GlobeNewswire

Millennium Blockchain Invests $5 Million in BurstIQ
07/03/2018
SANTA MONICA, CA, March 07, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain Inc. (OTC: MBLC ), a holding company focused on blockchain technologies and crypto-assets in financial markets, healthcare, crypto-mining and [...]
Chimerix to Present at Cowen and Company 38th Annual Health Care Conference
07/03/2018
DURHAM, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that M. [...]
Ultragenyx Announces Positive Topline Results and DMC Review from First Cohort of Phase 1/2 Clinical Study of DTX301, an Investigational Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
07/03/2018
Ureagenesis normalized in one patient and further increased by 24 weeks Cohort 2 patient enrollment to begin in March 2018; data expected in second half of 2018 NOVATO, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- [...]
WishBone Medical, Inc. and Hospital for Special Surgery (HSS) Collaborate to Develop a Novel Pediatric Total Hip Implant.
07/03/2018
NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants, entered into a license agreement with [...]
Delcath Announces Commercial Supply Agreement for Melphalan Hydrochloride for Injection with Tillomed Laboratories
07/03/2018
NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces it has entered into a [...]
Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at the Cowen Healthcare Conference on March 13, 2018, Tuesday at 8:40 AM ET
07/03/2018
RALEIGH, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory [...]
Actinium Pharmaceuticals to Present at 30th Annual ROTH Conference
07/03/2018
NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM) ("Actinium" or "the Company"), announced today that it will be attending and presenting at the 30 th Annual ROTH [...]
Idera Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update
07/03/2018
EXTON, Pa. and CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company focused on the discovery, development and [...]
Pacific Biosciences Enhances Performance and Affordability of Key Applications on the Sequel System
07/03/2018
MENLO PARK, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB ), the leader in long-read, high-resolution sequencing, today announced a new version of Sequel ® Software (V5 [...]
Summit Expands Enrolment in Phase 2 Clinical Trial to Include Planned Additional Group
07/03/2018
Summit Therapeutics plc ("Summit" or the "Company") Summit Expands Enrolment in PhaseOut DMD Phase 2 Clinical Trial to Include Planned Additional Group Additional Group is Open to Patients Who Participated in Phase 1 [...]
Allergy Therapeutics: Interim Results for the six months ended 31 December 2017
07/03/2018
Manuel Llobet, Chief Executive Officer, and Nick Wykeman, Finance Director, will host a meeting and call for analysts to provide an update on the Group, followed by a Q&A session, at 0930 GMT today. Dial-in details [...]
Summit Expands Enrolment in PhaseOut DMD Phase 2 Clinical Trial to Include Planned Additional Group
07/03/2018
Additional Group is Open to Patients Who Participated in Phase 1 Clinical Trials of Ezutromid Allows Summit to Gather Additional Safety and Efficacy Data from a Broader Patient Population OXFORD, United Kingdom, March [...]
BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2017 Financial Results on Thursday, March 15
07/03/2018
RALEIGH, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that [...]
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)
07/03/2018
ANAVEX®2-73 Extends Survival and Reduces Seizures in an Orphan Disease Model NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL ), a clinical-stage [...]
Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology
07/03/2018
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms [...]
Leap Therapeutics to Present at 2018 Barclays Global Healthcare Conference
07/03/2018
CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, [...]
Inovalon to Acquire ABILITY Network
07/03/2018
Combination Creates A Vertically Integrated Leader In Cloud-Based Enablement Of Data-Driven, Value-Based Care Accretive Transaction Accelerates Growth And Enhances Profitability Please refer to our Transaction [...]
BioVie Responds to Japan Patent Office and Comments on Recent Stock Price Decline
07/03/2018
BEVERLY, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, announced today that [...]
miRagen Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on March 14, 2018
07/03/2018
BOULDER, Colo., March 07, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ) a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]

Pages